RRC ID 11042
Author Koide S, Okazaki M, Tamura M, Ozumi K, Takatsu H, Kamezaki F, Tanimoto A, Tasaki H, Sasaguri Y, Nakashima Y, Otsuji Y.
Title PTEN reduces cuff-induced neointima formation and proinflammatory cytokines.
Journal Am. J. Physiol. Heart Circ. Physiol.
Abstract An inflammatory response followed by vascular injury plays an important role in neointima formation and development of atherosclerotic lesions, which are in part mediated by proinflammatory cytokines. Using a cuff injury model, we examined the effects of adenovirus-mediated overexpression of phosphatase and tensin homology deleted on chromosome 10 (PTEN) on neointima formation and the proinflammatory response. A cuff was placed around the femoral artery, and adenovirus expressing human PTEN type 1 (AdPTEN) or Escherichia coli beta-galactosidase (AdLacZ) was injected between the cuff and the adventitia. After 14 days, the arteries were examined histopathologically and by Western blotting. The significant reduction of neointima formation by AdPTEN compared with AdLacZ was accompanied by reduced cell proliferation and increased adventitial cell apoptosis. AdPTEN also reduced expression of phosphorylated I kappa B-alpha, but not nonphosphorylated I kappa B-alpha. Western blotting revealed that AdPTEN reduced the cuff injury-induced expression levels of monocyte chemoattractant protein-1, TNF-alpha, and IL-1 beta and their expression in all layers of the arterial wall. In contrast, cuff-induced macrophage invasion, which was also inhibited by AdPTEN, was detected only at the intimal surface and in the adventitia. In cultured vascular smooth muscle cells, PTEN directly inhibited ANG II-induced monocyte chemoattractant protein-1 expression as quantified by real-time PCR and Western blotting. Our results suggest that overexpression of PTEN reduces neointima formation, possibly in part through inhibition of the inflammatory response by macrophage invasion and proinflammatory cytokine expression.
Volume 292(6)
Pages H2824-31
Published 2007-6
DOI 10.1152/ajpheart.01221.2006
PII 01221.2006
PMID 17277022
MeSH Adenoviridae / genetics Angiotensin II / metabolism Animals Apoptosis Atherosclerosis / etiology* Atherosclerosis / genetics Atherosclerosis / metabolism Atherosclerosis / pathology Atherosclerosis / prevention & control Cell Proliferation Cells, Cultured Chemokine CCL2 / metabolism Cytokines / genetics Cytokines / metabolism* Disease Models, Animal Femoral Artery / metabolism* Femoral Artery / pathology Femoral Artery / surgery Genetic Therapy / methods* Genetic Vectors I-kappa B Proteins / metabolism Inflammation / complications Inflammation / genetics Inflammation / metabolism Inflammation / pathology Inflammation / prevention & control* Interleukin-1beta / metabolism Macrophages / metabolism Male Muscle, Smooth, Vascular / cytology Muscle, Smooth, Vascular / metabolism Myocytes, Smooth Muscle / metabolism NF-KappaB Inhibitor alpha PTEN Phosphohydrolase / genetics PTEN Phosphohydrolase / metabolism* Phosphorylation RNA, Messenger / metabolism Rats Rats, Wistar Transfection Tumor Necrosis Factor-alpha / metabolism Tunica Intima / metabolism* Tunica Intima / pathology
IF 3.348
Times Cited 21
WOS Category CARDIAC & CARDIOVASCULAR SYSTEMS PHYSIOLOGY PERIPHERAL VASCULAR DISEASE
Resource
DNA material AxCAhPTEN1 (RDB02012)
Human and Animal Cells 293 (RCB1637)